Three randomized trials have concluded at non inferiority of omission of complementary axillary lymph node dissection (cALND) for patients with involved sentinel node (SN). | Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial Axillary dissection versus no axillary dissection in patients with involved sentinel node